Alferez, Monaliza .

HRN: 28-71-86  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2026
CO-AMOXICLAV 625MG (TAB)
03/24/2026
03/30/2026
ORAL
625mg
BID
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: